HOT Off The Press

Popular Holdings Ltd. increases its holdings in Popular Kids


Popular Holdings acquires 14,040 shares from a shareholder of subsidiary Popular Kids Co., Ltd. for a total consideration of $NT 7,020.00.

This increases the holdings of the company from 90.0% to 90.7%

The transaction was carried out with internal resources and is not expected to have any effect on the earnings per share or the net tangible assets per share stated in the recently ended financial year.

Popular is making fast and extensive inroads into the Greater China market, especially in China and Taiwan. They have marketing offices / subsidiaries in Beijing, Shenzhen, Guangzhou and Taipei. Our business activities cover many major cities and provinces in China. The company has businesses in book retail and distribution, publishing and e-learning.

Union Steel subsidiary acquires S'pore property

Union Steel Pte Ltd. a subsidiary of Union Steel Holdings Limited has been given the option of buying No. 12 Tanjong Gul Road, Singapore 629343 for $5,500,000 from Sea Containers Asia Pte. Ltd.

The property purchase will help facilitate expansion and development plans for company operations.

The transaction will be financed through bank loans and internal funds.

The Group is principally engaged in the recycling of ferrous and non-ferrous scrap metals, the trading of steel products and the provision of other services, comprising waste collection and management, demolition works, rental of steel plates and car scrapping. They serve a wide customer base of over 500 customers, spanning across countries such as China, India, Indonesia, Japan, Malaysia and Singapore. The company intends to seek expansion opportunities within both its existing and potential markets via possible acquisitions and joint ventures in China and Indonesia.

Sembawang Music acquires share in Falcon and FEG

Sembawang Music Holdings Limited acquires one ordinary share in both Falcon Energy Projects, and FEG Offshore.

Both purchases were made at $1.00 per ordinary share.

The two companies are now considered wholly owned subsidiaries of Sembawang Music.

Sembawang Music is the largest music and visual products retail chain store operator by number of stores in Singapore. The Group operates a chain of 20 Sembawang Music retail outlets offering Audio CDs, DVDs, VCDs and related audio and visual products and a separate outlet called "Audiophile" which also retails Audio CDs, DVDs and VCDs, with a combined gross floor area of approximately 16,364 sq. ft.. The outlets are strategically located at major shopping centres in different parts of Singapore. The group's retail business is currently limited to Singapore.

Brilliant accepts voluntary offer by Daiwa


Brilliant Manufacturing Limited shareholders have accepted the voluntary conditional cash offer made by Daiwa Securities SMBC Singapore Limited

As of now, the amount of shares offered to Daiwa is 274,921,000 or 58.98% of the issued and paid up share capital of the company.

Daiwa has made the offer on behalf of Japan-based Nidec Corporation.

Brilliant Manufacturing was established as a private limited company in 1984 to do precision machining of 5.25" floppy disk drive aluminium housing for Tandon in Singapore. After the acquisition of Tandon by Western Digital, The company grew substantially from servicing Western Digital to other valued customers in the Hard Disk Drive ("HDD") sector. In 1998, the Company was listed on SGX as Brilliant Manufacturing Limited.It has since grown to become a group of companies spanning four countries in Asia serving the HDD-related business specialising in the production of aluminium base plates, brackets and stamped metal top-covers.

Asiapharm announces acquisitions of pharmaceutical companies

The group has purchased a Nanjing-based pharmaceutical group specialising in oncology for RMB 345m. The acquisition is expected to enhance the group's market penetration rate in PRC.

The shares to be issued in total are 5.0 million shares at S$0.60 per share with par value of US$0.02.

The group's core businesses include: research, development, production and sale of pharmaceutical drugs for the fields of orthopaedics, neurology, gastroenterology and hepatology, focusing on natural drugs and chemical drugs with new formulations ;distribution of products of other pharmaceutical manufacturers in the PRC; processing and sale of active ingredients, mainly chondroition sulphate, for the manufacture of pharmaceutical drugs; and sale of R&D results and/or patents of new drugs and provision of research services on a contract basis.

CEO's Walk The Talk

"…Just as a long-distance runner cannot constantly focus on short-term leads over his competitors, as a medical device company, we also cannot be distraught over short-term projected non-profitability as long as we know that our current spending will further enhance and support attainment of our future goals. We are akin a long-distance runner who should plan the race and store sufficient energy with consistent practice to condition the muscles to take on the challenge. If we do not do that, we will not be able to complete and eventually win the race…"
Lu Yoh-Chie
CEO
Biosensors International

Highlighted Company


Established in 1994, the company is one of the leading specialty pharmaceutical groups in the PRC. They specialise in the research, development, production and sale of pharmaceutical drugs and new formulations for chemical drugs, the sale of R&D results and patents for new drugs, and the provision of research services on a contract basis.

Their ultra modern facility in Yantai is fully equipped with leading edge technology, fully integrated and GMP certified, enabling the facilitating of all aspects of pre-clinical evaluation; from pharmaceutical to pharmacology research, drug safety evaluation and clinical trials; to the full production of our natural drugs.

The company currently employs more than 100 researchers and has close collaborative relationships with renowned universities and research institutions to drive our R&D efforts, enabling them to stay at the forefront of specialty pharmaceutical developments.

The company has established an extensive distribution network of 35 sales support offices, covering 30 provinces, municipals, and autonomous regions, reaching approximately 2,000 hospitals. This is further supported by a strong network of 250 distributors and 280 sales and marketing personnel.